Evaluation of Wnt5a and LRP5 Levels in Serum and Saliva Samples and the Relationship Between Clinical Periodontal Parameters
Launched by ANKARA UNIVERSITY · Apr 16, 2025
Trial Information
Current as of June 10, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • \>18 years old,
- • At least 16 permanent teeth except 3rd molars,
- • Individuals who do not use orthodontic appliances,
- • Individuals who are not pregnant or lactating,
- • Individuals without any systemic disease that may affect periodontal health,
- • Systemically healthy individuals,
- • Individuals who have not used anti-inflammatory and/or anti-microbial drugs in the last 6 months,
- • Individuals who have not received periodontal treatment in the last 1 year
- Exclusion Criteria:
- • Pregnant/lactating individuals,
- • Individuals who have used anti-inflammatory and/or anti-microbial drugs in the last 6 months,
- • Individuals who have undergone periodontal treatment in the last 1 year,
- • Individuals with psychiatric illness,
- • Individuals with any oral infection,
- • Individuals with \<16 teeth, excluding molars,
- • Individuals with alcohol dependence,
- • Individuals with active infectious disease (acute hepatitis, AIDS, tuberculosis), cancer or any systemic condition that may affect periodontal tissues,
- • Individuals receiving treatment with drugs known to affect periodontal tissues (phenytoin, cyclosporine A, calcium channel blockers)
About Ankara University
Ankara University, a prominent institution in Turkey, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on scientific rigor and ethical standards, the university collaborates with various stakeholders to design and implement studies that address critical health challenges. Leveraging a diverse network of experienced researchers and state-of-the-art facilities, Ankara University aims to contribute significantly to the global medical community by generating valuable insights and fostering the development of effective therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, Yenimahalle, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported